Louis Burt Nabors (L Burt Nabors, Burt Nabors, Louis B Nabors)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Neuro-oncology advances

JCO oncology practice

Cancer research

University of Alabama at Birmingham

Mississippi State University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Alabama at Birmingham

United States

Professor :: Neurology

US Navy

United States

Flight Surgeon :: Medicine

Education History

Mississippi State University

United States

BSC :: Biological Engineering

Publications

Samuel A Goldlust, Louis Burt Nabors, Sigmund Hsu, Nimish Mohile, Paul J Duic, Tara Benkers, Samuel Singer, Mayank Rao, Lori Cappello, Sandra L Silberman, George Farmer
Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma. Neuro-oncology advances 6 (1) (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Samuel A Goldlust, Louis Burt Nabors, Sigmund Hsu, Nimish Mohile, Paul J Duic, Tara Benkers, Samuel Singer, Mayank Rao, Lori Cappello, Sandra L Silberman, George Farmer
Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma. Neuro-oncology advances 6 (1) (2024)
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil D Dhruv, Yue Hao, Michael E Berens, Tobias Walbert, Matthias Holdhoff, Glenn J Lesser, Timothy F Cloughesy, Andrew E Sloan, Naoko Takebe, Marta Couce, David M Peereboom, Louis Burt Nabors, Patrick Yung Wen, Stuart A Grossman, Lisa R Rogers
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil D Dhruv, Yue Hao, Michael E Berens, Tobias Walbert, Matthias Holdhoff, Glenn J Lesser, Timothy F Cloughesy, Andrew E Sloan, Naoko Takebe, Marta Couce, David M Peereboom, Louis Burt Nabors, Patrick Yung Wen, Stuart A Grossman, Lisa R Rogers
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil D Dhruv, Yue Hao, Michael E Berens, Tobias Walbert, Matthias Holdhoff, Glenn J Lesser, Timothy F Cloughesy, Andrew E Sloan, Naoko Takebe, Marta Couce, David M Peereboom, Louis Burt Nabors, Patrick Yung Wen, Stuart A Grossman, Lisa R Rogers
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Lauren R Schaff, Dean Carlow, Ryan Schofield, Venissala Wongchai, Juli Madzsar, Allison Hyde, Anne S Reiner, Katherine S Panageas, Lisa M DeAngelis, Ingo K Mellinghoff, Mina Lobbous, Louis Burt Nabors, Christian Grommes
Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS Lymphoma. JCO oncology practice (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil D Dhruv, Yue Hao, Michael E Berens, Tobias Walbert, Matthias Holdhoff, Glenn J Lesser, Timothy F Cloughesy, Andrew E Sloan, Naoko Takebe, Marta Couce, David M Peereboom, Louis Burt Nabors, Patrick Yung Wen, Stuart A Grossman, Lisa R Rogers
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil D Dhruv, Yue Hao, Michael E Berens, Tobias Walbert, Matthias Holdhoff, Glenn J Lesser, Timothy F Cloughesy, Andrew E Sloan, Naoko Takebe, Marta Couce, David M Peereboom, Louis Burt Nabors, Patrick Yung Wen, Stuart A Grossman, Lisa R Rogers
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Rifaquat Rahman, Lorenzo Trippa, Eudocia Quant Lee, Isabel C Arrillaga-Romany, Geoffrey Fell, Mehdi Touat, Christine McCluskey, Jennifer Wiley, Sarah Gaffey, Jan Drappatz, Mary R Welch, Evanthia Galanis, Manmeet S Ahluwalia, Howard Colman, Louis Burt Nabors, Jaroslaw Hepel, Heinrich Elinzano, David Schiff, Ugonma N Chukwueke, Rameen Beroukhim, Lakshmi Nayak, J Ricardo McFaline-Figueroa, Tracy T Batchelor, Mikael L Rinne, Thomas J Kaley, Christine Lu-Emerson, Ingo K Mellinghoff, Wenya Linda Bi, Omar Arnaout, Pier Paolo Peruzzi, Daphne A Haas-Kogan, Shyam Tanguturi, Daniel Cagney, Ayal A Aizer, Lisa Doherty, Maria Lavallee, Brittany Fisher-Longden, Shanna Dowling, Jack Geduldig, Fiona Watkinson, William Pisano, Seth Malinowski, Shakti Ramkissoon, Sandro Santagata, David M Meredith, E Antonio Chiocca, David A Reardon, Brian M Alexander, Keith L Ligon, Patrick Yung Wen
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Dagoberto Estevez-Ordonez, Moaaz Abdelrashid, Elizabeth Coffee, Nicholas M B Laskay, Travis J Atchley, Rati Chkheidze, John B Fiveash, James M Markert, Mina Lobbous, Brandon M Maveal, Louis Burt Nabors
Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort study. Cancer (2023)
Natalia Filippova, Jeffrey M Grimes, Jianmei W Leavenworth, David Namkoong, Xiuhua Yang, Peter H King, Michael Crowley, David K Crossman, Louis Burt Nabors
Targeting the TREM1-positive myeloid microenvironment in glioblastoma. Neuro-oncology advances 4 (1) (2022)
Stephen J Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Quant Lee, Gavin P Dunn, Evanthia Galanis, Susan M Chang, Louis Burt Nabors, Manmeet S Ahluwalia, Roger Stupp, Minesh P Mehta, David A Reardon, Stuart A Grossman, Erik P Sulman, John H Sampson, Simon Khagi, Michael Weller, Timothy F Cloughesy, Patrick Y Wen, Mustafa Khasraw
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Christine Woo, Gino N Cioffi, Taissa A Bej, Brigid Wilson, Janet M Briggs, Sarah C Markt, Fredrick R Schumacher, Carol Kruchko, Kristin A Waite, Louis Burt Nabors, Charles J Nock, Robin L P Jump, Jill S Barnholtz-Sloan
Data Matching to Support Analysis of Cancer Epidemiology Among Veterans Compared With Non-Veteran Populations-An Exemplar in Brain Tumors. JCO clinical cancer informatics 5 (2021)
Julia Furtner, Michael Weller, Michael Weber, Thierry Gorlia, Louis Burt Nabors, David A Reardon, Joerg C Tonn, Roger Stupp, Matthias Preusser, null null
Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Rajeshwari Chellappan, Abhishek Guha, Ying Si, Thaddaeus Kwan, Louis Burt Nabors, Natalia Filippova, Xiuhua Yang, Anish S Myneni, Shriya Meesala, Ashley S Harms, Peter H King
SRI-42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide-induced neuroinflammation. Glia 70 (1) (2021)
Soniya Bastola, Marat S Pavlyukov, Daisuke Yamashita, Sadashib Ghosh, Heejin Cho, Noritaka Kagaya, Zhuo Zhang, Mutsuko Minata, Yeri Lee, Hirokazu Sadahiro, Shinobu Yamaguchi, Svetlana Komarova, Eddy Shih-Hsin Yang, James Markert, Louis Burt Nabors, Krishna Bhat, James Lee, Qin Chen, David K Crossman, Teppei Kawahara, Do-Hyun Nam, Ichiro Nakano
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy. Nature communications 11 (1) (2020)
Jordan H Creed, Noah C Peeri, Gabriella M Anic, Reid C Thompson, Jeffrey J Olson, Renato V LaRocca, Sajeel A Chowdhary, John D Brockman, Travis A Gerke, Louis Burt Nabors, Kathleen M Egan
Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of glioma. Scientific reports 9 (1) (2019)
Hassan M Fathallah-Shaykh, Andrew B DeAtkine, Elizabeth Coffee, Elias Khayat, Asim K Bag, Xiaosi Han, Paula Province Warren, Markus Bredel, Kristen O Riley, James Markert, Nidhal Bouaynaya, Louis Burt Nabors
Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study. PLoS medicine 16 (5) (2019)
Monika E Hegi, Els Genbrugge, Thierry Gorlia, Roger Stupp, Mark R Gilbert, Olivier Louis Chinot, Louis Burt Nabors, Greg Jones, Wim Van Criekinge, Josef Straub, Michael Weller
MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (6) (2018)
Jaishri O Blakeley, Stuart A Grossman, Andrew S Chi, Tom Mikkelsen, Myrna R Rosenfeld, Manmeet S Ahluwalia, Louis Burt Nabors, April Eichler, Ignacio Garcia Ribas, Serena Desideri, Xiaobu Ye, null null
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (1) (2018)
Hirokazu Sadahiro, Kyung-Don Kang, Justin T Gibson, Mutsuko Minata, Hai Yu, Junfeng Shi, Rishi Chhipa, Zhihong Chen, Songjian Lu, Yannick Simoni, Takuya Furuta, Hemragul Sabit, Suojun Zhang, Soniya Bastola, Shinobu Yamaguchi, Heba Allah M Alsheikh, Svetlana Komarova, Jun Wang, Sung Hak Kim, Dolores Hambardzumyan, Xinghua Lu, Evan W Newell, Biplab DasGupta, Mitsutoshi Nakada, L James Lee, Louis Burt Nabors, Lyse A Norian, Ichiro Nakano
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma. Cancer research 78 (11) (2018)

Louis Burt Nabors.css-eqlu8i{font-size:small;padding-left:4px;} (L Burt Nabors, Burt Nabors, Louis B Nabors)

Publication Activity (10 Years)

Top Topics

Top Venues

Louis Burt Nabors (L Burt Nabors, Burt Nabors, Louis B Nabors)